Original Research
Hypertension among human immunodeficiency virus infected patients on treatment at Parirenyatwa Hospital: A descriptive study
Submitted: 11 October 2018 | Published: 19 August 2019
About the author(s)
Rumbidzai Chireshe, Discipline of Nursing and Public Health, University of KwaZulu-Natal, Durban, South AfricaKeshena Naidoo, School of Nursing, Public Health and Family Medicine, University of KwaZulu-Natal, Durban, South Africa
Rudo Nyamakura, Department of Nursing Science, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe
Abstract
Background: Since the roll-out of antiretroviral therapy (ART) in sub-Saharan Africa (sSA) in the early 2000s, the life expectancy of people infected with the human immunodeficiency virus (HIV) has increased. However, the gains made in reducing mortality from HIV-related complications have been mitigated by the emergence of age-related chronic non-communicable diseases (NCDs), such as hypertension. Protease inhibitors (PIs), and prolonged exposure to highly active ART (HAART) have been implicated in the development of hypertension in HIV-positive people.
Aim: To investigate the prevalence of hypertension and its associated risk factors among HIV-positive patients receiving ART.
Setting: The study was carried out at an urban-based clinic that provides HAART and primary care to HIV-positive people in Harare, Zimbabwe.
Methods: A descriptive, cross-sectional study was conducted among non-pregnant adults on HAART attending the clinic between July and August 2018.
Results: We studied 600 HIV-positive adult patients, of which 56% were women. The prevalence rate of hypertension was 29.9%. Of the participants in the hypertensive group, 11.2% were not previously diagnosed or on treatment. Factors associated with hypertension were advanced age, use of HAART for longer than 10 years, being overweight, a family history of hypertension and smoking. There was a 68.8% prevalence of body mass index greater than 25 kg/m2 among all participants.
Conclusion: High hypertension prevalence was recorded. Hypertension was not associated with gender or use of PI regimens but being overweight was highly prevalent. Greater vigilance and integration of resources is required in the overall treatment and monitoring of HIV-positive patients for co-morbidities.
Keywords
Metrics
Total abstract views: 3470Total article views: 5569
Crossref Citations
1. High Prevalence of AH in HIV Patients on ART, in Bahia, Brazil
Daniel Vargas-Pacherrez, Carlos Brites, Helma P. Cotrim, Carla Daltro
Current HIV Research vol: 18 issue: 5 first page: 324 year: 2020
doi: 10.2174/1570162X18666200620212547
2. Hypertension among people living with human immunodeficiency virus receiving care at referral hospitals of Northwest Ethiopia: A cross-sectional study
Alemu Gebrie, Samson Gebremedhin
PLOS ONE vol: 15 issue: 8 first page: e0238114 year: 2020
doi: 10.1371/journal.pone.0238114
3. The Burden of Hypertension in HIV-Infected Adults on Retroviral Therapy in Masvingo Province, Zimbabwe: A Retrospective Cohort Study
Kudzai Masunda, Zahid Khan
Cureus year: 2023
doi: 10.7759/cureus.46476
4. Blood Pressure and Blood Glucose Control and Associated Factors Among Adults with Hypertension at Three Public Hospitals in Southern Ethiopia
Mende Mensa Sorato, Majid Davari, Abbas Kebriaeezadeh, Nizal Sarrafzadegan, Tamiru Shibru
High Blood Pressure & Cardiovascular Prevention vol: 29 issue: 3 first page: 287 year: 2022
doi: 10.1007/s40292-022-00516-7
5. Trends, prevalence and factors associated with hypertension and diabetes among South African adults living with HIV, 2005–2017
Nicola Chiwandire, Nompumelelo Zungu, Musawenkosi Mabaso, Charles Chasela
BMC Public Health vol: 21 issue: 1 year: 2021
doi: 10.1186/s12889-021-10502-8
6. Magnitude of Hypertension and Associated Factors Among Human Immunodeficiency Virus Positive Adults Receiving Anti-Retroviral Therapy at Debre Markos Referral Hospital, Northwest, Ethiopia
Yihenew Sewale, Abebe Dilie Afenigus, Dessalegn Haile, Wondimeneh Shibabaw Shiferaw
HIV/AIDS - Research and Palliative Care vol: Volume 12 first page: 629 year: 2020
doi: 10.2147/HIV.S280630
7. Prevalence and Predictive Factors of Hypertension Among People Living With HIV in Kebbi State, Nigeria: A Cross-sectional Study
Oluwaseun Badru, Taofik Oduola, Aisha Abdulrazaq, Chigozie Peter
Journal of the Association of Nurses in AIDS Care vol: 33 issue: 1 first page: e6 year: 2022
doi: 10.1097/JNC.0000000000000309
8. Prevalence and factors associated with hypertension among peoples living with HIV in East Africa, a systematic review and meta-analysis
Kirubel Dagnaw Tegegne, Getachew Asmare Adela, Gizachew Ambaw Kassie, Misganaw Asmamaw Mengstie, Mohammed Abdu Seid, Melkamu Aderajaw Zemene, Sefineh Fenta Feleke, Tadesse Asmamaw Dejenie, Endeshaw Chekol Abebe, Denekew Tenaw Anley, Anteneh Mengist Dessie, Molalign Melese Gesese, Nega Yimer, Natnael Atnafu Gebeyehu
BMC Infectious Diseases vol: 23 issue: 1 year: 2023
doi: 10.1186/s12879-023-08679-x
9. HIV and cardiovascular disease in sub-Saharan Africa: Demographic and Health Survey data for 4 countries
Leonard E. Egede, Rebekah J. Walker, Patricia Monroe, Joni S. Williams, Jennifer A. Campbell, Aprill Z. Dawson
BMC Public Health vol: 21 issue: 1 year: 2021
doi: 10.1186/s12889-021-11218-5
10. A qualitative exploratory study of selected physicians’ perceptions of the management of non-communicable diseases at a referral hospital in Zimbabwe
Alexander Cheza, Boikhutso Tlou
Globalization and Health vol: 17 issue: 1 year: 2021
doi: 10.1186/s12992-021-00730-3
11. Time to hypertension development among people living with HIV in South Africa: A longitudinal analysis of the National Income Dynamics Survey (NIDS)
Motlatso Godongwana, Nicole De Wet-Billings
Heliyon vol: 7 issue: 8 first page: e07750 year: 2021
doi: 10.1016/j.heliyon.2021.e07750
12. Integrated chronic care models for people with comorbid of HIV and non-communicable diseases in Sub-Saharan Africa: A scoping review
Rumbidzai Chireshe, Tawanda Manyangadze, Keshena Naidoo, Adobea Yaa Owusu
PLOS ONE vol: 19 issue: 3 first page: e0299904 year: 2024
doi: 10.1371/journal.pone.0299904

